ANL (Adlai Nortye) Other Current Receivables: $1.39 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Adlai Nortye Other Current Receivables?

Adlai Nortye ANL +0.27% Other Current Receivables is $1.39 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Adlai Nortye's Other Current Receivables for the quarter that ended in Dec. 2025 was $1.39 Mil.

Adlai Nortye's quarterly Other Current Receivables increased from Dec. 2024 ($1.17 Mil) to Jun. 2025 ($3.09 Mil) but then stayed the same from Jun. 2025 ($3.09 Mil) to Dec. 2025 ($1.39 Mil).

Adlai Nortye's annual Other Current Receivables increased from Dec. 2023 ($0.36 Mil) to Dec. 2024 ($1.17 Mil) and increased from Dec. 2024 ($1.17 Mil) to Dec. 2025 ($1.39 Mil).

Adlai Nortye Other Current Receivables Related Terms

Adlai Nortye Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Adlai Nortye's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye Other Current Receivables Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
1.93 0.35 0.36 1.17 1.39

Adlai Nortye Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 0.36 2.30 1.17 3.09 1.39

Adlai Nortye Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $1.39 Mil mean?
Adlai Nortye (ANL) has a Other Current Receivables of $1.39 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Adlai Nortye and its competitors.
Is Adlai Nortye's Other Current Receivables too high?
Adlai Nortye's current Other Current Receivables is $1.39 Mil.
How does Adlai Nortye's Other Current Receivables compare to OMER and PRME?
Adlai Nortye's Other Current Receivables of $1.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Adlai Nortye and its competitors. Adlai Nortye's current Other Current Receivables is $1.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adlai Nortye stock overvalued right now?
Adlai Nortye (ANL) has a current Other Current Receivables of $1.39 Mil. The current Other Current Receivables is $1.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Adlai Nortye (ANL), the current Other Current Receivables is $1.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adlai Nortye Business Description

Other Exchanges N2U0:Germany
Address 685 US Highway 1, New Jersey Biotechnology Development Center, 2nd Floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.